L-carnitine and contribution to normal lipid metabolism : evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Visa fullständig post



Permalänk

http://hdl.handle.net/10138/298818

Citation

EFSA Panel Dietetic Prod Nut 2018 , ' L-carnitine and contribution to normal lipid metabolism : evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 ' , EFSA Journal , vol. 16 , no. 1 , 5137 . https://doi.org/10.2903/j.efsa.2018.5137

Titel: L-carnitine and contribution to normal lipid metabolism : evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
Författare: EFSA Panel Dietetic Prod Nut
Upphovmannens organisation: Department of Food and Nutrition
Food Quality & Safety
Food Sciences
Datum: 2018-01
Språk: eng
Sidantal: 9
Tillhör serie: EFSA Journal
ISSN: 1831-4732
DOI: https://doi.org/10.2903/j.efsa.2018.5137
Permanenta länken (URI): http://hdl.handle.net/10138/298818
Abstrakt: Following an application from Lonza Ltd., submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No1924/2006 via the Competent Authority of Germany, the EFSA Panelon Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to L-carnitine and normal lipid metabolism. The food that is proposed as the subject of the health claim is L-carnitine. The Panelconsiders that L-carnitine is sufficiently characterised. The claimed effect proposed by the applicant is normal lipid metabolism'. The target population proposed by the applicant is the general population. The Panelconsiders that contribution to normal lipid metabolism is a beneficial physiological effect. The applicant proposes that the claim submitted with this application is based on the essentiality of a nutrient. The Panelconsiders that the evidence provided does not establish that dietary L-carnitine is required to maintain normal lipid metabolism in the target population, for which the claim is intended. The Panelconcludes that a cause and effect relationship has not been established between the consumption of L-carnitine and contribution to normal lipid metabolism in the target population. (c) 2018 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.
Subject: L-carnitine
lipid metabolism
health claim
PARENTERAL-NUTRITION
REQUIREMENTS
OXIDATION
GUIDANCE
CYCLE
416 Food Science
Referentgranskad: Ja
Licens: cc_by_nd
Användningsbegränsning: openAccess
Parallelpublicerad version: publishedVersion


Filer under denna titel

Totalt antal nerladdningar: Laddar...

Filer Storlek Format Granska
Panel_et_al_2018_EFSA_Journal_4.pdf 565.9Kb PDF Granska/Öppna

Detta dokument registreras i samling:

Visa fullständig post